Copyright
©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 7, 2005; 11(9): 1382-1386
Published online Mar 7, 2005. doi: 10.3748/wjg.v11.i9.1382
Published online Mar 7, 2005. doi: 10.3748/wjg.v11.i9.1382
Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma
Bu-Dong Zhu, Qi-Cheng Zhao, Xin Li, Yan Li, Qi-Ying Lu, Department of Medical Oncology, Peking University School of Oncology and Beijing Institute for Cancer Research, Beijing Cancer Hospital, Beijing 100036, China
Shou-Jun Yuan, Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Bu-Dong Zhu, Department of Medical Oncology, Peking University School of Oncology and Beijing Institute for Cancer Research, Beijing Cancer Hospital, Beijing 100036, China. zhubd@tom.com.cn
Telephone: +86-10-88121122 Fax: +86-10-88122437
Received: May 25, 2004
Revised: May 28, 2004
Accepted: June 17, 2004
Published online: March 7, 2005
Revised: May 28, 2004
Accepted: June 17, 2004
Published online: March 7, 2005
Core Tip